Food and Drug Administration

Baby-formula manufacturers and retailers say they are working to address a long-running shortage in products on store shelves but the hardships facing U.S. families may take months to abate. Abbott Laboratories, ABT 1.59% producer of Similac baby formula, said it is bringing products from its factory in Ireland to the U.S. as it continues talks with the Food and Drug Administration to restart production at its factory in Michigan. However, the company has said it would…

Abbott Laboratories said it could resume infant formula production within two weeks at a Michigan manufacturing plant that has been shut since February because of bacterial contamination concerns, exacerbating a nationwide formula shortage. The Illinois-based company said Wednesday it would resume production pending approval from the Food and Drug Administration, which has been conducting an investigation into whether bacterial contamination at the plant…